Proto Script Pharmaceutical

Proto Script Pharmaceutical Book Value per Share

Book Value per Share of Proto Script Pharmaceutical (PSCR) as of Oct 9, 2026.

Book Value per Share

-0.00USD

YoY

-223.81%

Last updated:

Book Value per Share of Proto Script Pharmaceutical is 2016 -0.00 USD. Book Value per Share of Proto Script Pharmaceutical was 2015 0.00 USD. It decreases by -223.81% lower compared to the previous year.

The Proto Script Pharmaceutical Book Value per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Book Value per Share
Date
Book Value per Share
Jan 1, 2014
0.01 USD
Jan 1, 2015
0.00 USD
Jan 1, 2016
-0.00 USD
The Proto Script Pharmaceutical Book Value per Share history
YEARBook Value per ShareYoY
-0.00USD-223.81%
0.00USD-80.76%
0.01USD—
Access this data via the Eulerpool API

Proto Script Pharmaceutical Stock analysis

What does Proto Script Pharmaceutical do? Proto Script Pharmaceutical Corp is an American biotechnology company specializing in the development and manufacture of innovative, high-quality drugs. The company is focused on researching new breakthrough technologies in drug manufacturing to find potential cures and treat diseases. Their business model is based on producing medications that are highly effective and of high quality while also being cost-effective and patient-friendly. They collaborate closely with biotechnology companies and academic institutions to acquire the best technologies and develop effective and innovative drugs. They have products in the areas of neurology, endocrine health, and oncology. They have also entered into partnerships with other companies to expand and further develop their products. Overall, Proto Script Pharmaceutical Corp is a groundbreaking company in the biotechnology field with decades of experience in drug development and a commitment to improving the lives of millions of people worldwide. Proto Script Pharmaceutical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Proto Script Pharmaceutical stock

On Eulerpool you can find the complete historical development of Book Value per Share Proto Script Pharmaceutical since 2006 – with annual values, charts, and detailed analysis.

Book value per share represents the net asset value of the company per outstanding share. Comparing it to the stock price helps assess whether a stock is undervalued.

Access this data via the Eulerpool API

Balance Sheet — Proto Script Pharmaceutical

All Key Metrics — Proto Script Pharmaceutical